agree once mkt reads thru it & the business model going forward a good re rate could be in the offering,, buying good revenue numbers & decent ebit a lot better then most.dyor
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025